Purpose/Objectives of the Study: Regenerative medicine, as well as aesthetic plastic surgery and dermatology field persistently seeks innovative, minimally invasive interventions to enhance skin quality and mitigate signs of aging. This study evaluates the regenerative capabilities of a new medical device focused on dermal redensification, induced by injections of single-strand alpha 1 collagen, to verify its ability, in a specific formulation (contained within a matrix of hyaluronic acid and carboxymethylcellulose), to induce dermal stimulation in both scar outcomes and regenerative medicine applied to skin aging.
Age range
20 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
"Change from Baseline to day 15 in the mean depth of skin wrinkles (mm)
Timeframe: baseline and day 15
"Change from Baseline to day 30 in the mean depth of skin wrinkles (mm)
Timeframe: baseline and day 30
"Change from Baseline to day 60 in the mean depth of skin wrinkles (mm)
Timeframe: baseline and day 60
"Change from Baseline to day 15 in melanin quantity ( arbitrary unit from 0.1-1 indicated by Antera 3D scanner)
Timeframe: baseline and day 15
"Change from Baseline to day 30 in melanin quantity ( arbitrary unit from 0.1-1 indicated by Antera 3D scanner)
Timeframe: baseline and day 30
"Change from Baseline to day 60 in melanin quantity ( arbitrary unit from 0.1-1 indicated by Antera 3D scanner)
Timeframe: baseline and day 60
"Change from Baseline to day 15 in hemoglobin quantity.
Timeframe: baseline and day 15
"Change from Baseline to day 30 in hemoglobin quantity.
Timeframe: baseline and day 30
"Change from Baseline to day 60 in hemoglobin quantity.
Timeframe: baseline and day 60
"Change from Baseline in the Mean values of FACE-Q questionnaire at 15 days"
Timeframe: baseline and day 15
"Change from Baseline in the Mean values of FACE-Q questionnaire, at 30 days"
Timeframe: baseline and day 30
"Change from Baseline in the Mean values of FACE-Q questionnaire, at 60 days"
Timeframe: baseline and day 60
"Change from Baseline in the Mean values of GAIS Global Aesthetic Improvment Scale, at 15 days"
Timeframe: baseline and day 15
"Change from Baseline in the Mean values of GAIS Global Aesthetic Improvment Scale, at 30 days"
Timeframe: baseline and day 30
"Change from Baseline in the Mean values of GAIS Global Aesthetic Improvment Scale, at 60 days"
Timeframe: baseline and day 60